References
- Perry T L, Urquhart N, MacLean J, et al. Nonketotic hyperglycinemia. Glycine accumulation due to absence of glycine cleavage in brain. N Engl J Med 1975; 292: 1269–73
- Hayasaka K, Tada K, Kikuchi G, Winter S, Nyhnan W L. Nonketotic hyperglycinemia: Two patients with primary defects of P‐protein and T‐protein, respectively, in the glycine cleavage system. Pediatr Res 1983; 17: 967–70
- Dobyns W B. Agenesis of the corpus callosum and gyral malformations are frequent manifestations of nonketotic hyperglycinemia. Neurology 1989; 39: 817–20
- Kolodny E H. Agenesis of the corpus callosum: A marker for inherited metabolic disease?. Neurology 1989; 39: 847–8
- Weinstein S L, Novotny E J, Jr. Neonatal metabolic disorders masquerading as structural central nervous system anomalies (abstract). Ann Neurol 1987; 22: 406
- Warburton D, Boyle R J, Keats J P, Vohr B, Peuschel S, Oh W. Nonketotic hyperglycinemia: Effects of therapy with strychnine. Am J Dis Child 1980; 134: 273–5
- Garcia‐Castro J M, Isales‐Forsythe C M, Levy H L, et al. Prenatal diagnosis of nonketotic hyperglycinemia. N Engl J Med 1982; 306: 79–81
- Von Wendt L, Simila S, Saukkonen A L, Koivisto M, Kouvalainen K. Prenatal brain damage in nonketotic hyperglycinemia. Am J Dis Child 1981; 135: 1072
- Garcia‐Munoz M J, Belloque J, Merinero B, Perez‐Cerda C, Sanz P, Ugarte M. Nonketotic hyperglycinaemia: Glycine/serine ratio in amniotic fluid—an unreliable method for prenatal diagnosis. Prenat Diagn 1989; 9: 473–6
- Bamforth F, Bamforth S, Poskitt K, Applegarth D, Hall J. Abnormalities of the corpus callosum in patients with inherited metabolic diseases (letter). Lancet 1988; 2: 451